Yunxiao Meng

1.4k total citations
32 papers, 909 citations indexed

About

Yunxiao Meng is a scholar working on Oncology, Neurology and Molecular Biology. According to data from OpenAlex, Yunxiao Meng has authored 32 papers receiving a total of 909 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 11 papers in Neurology and 10 papers in Molecular Biology. Recurrent topics in Yunxiao Meng's work include Myasthenia Gravis and Thymoma (6 papers), Neuroendocrine Tumor Research Advances (4 papers) and Neuroblastoma Research and Treatments (4 papers). Yunxiao Meng is often cited by papers focused on Myasthenia Gravis and Thymoma (6 papers), Neuroendocrine Tumor Research Advances (4 papers) and Neuroblastoma Research and Treatments (4 papers). Yunxiao Meng collaborates with scholars based in China, United States and Pakistan. Yunxiao Meng's co-authors include Shuangni Yu, Zhaohui Lu, Yihui Ma, Wugan Zhao, Jianping Liu, Jia Yu, Changzheng Liu, Jie Chen, Jie Chen and Yalan Bi and has published in prestigious journals such as Nature Communications, PLoS ONE and Cancer Research.

In The Last Decade

Yunxiao Meng

30 papers receiving 903 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yunxiao Meng China 17 510 339 261 113 101 32 909
Fernando Pardal Portugal 16 404 0.8× 211 0.6× 236 0.9× 48 0.4× 70 0.7× 26 829
Katharina König Germany 14 564 1.1× 246 0.7× 357 1.4× 35 0.3× 121 1.2× 20 1.0k
Ryo Nagashio Japan 20 626 1.2× 202 0.6× 300 1.1× 65 0.6× 100 1.0× 56 1.0k
Haizhen Lu China 13 264 0.5× 128 0.4× 231 0.9× 57 0.5× 113 1.1× 47 687
Bradley Wubbenhorst United States 14 449 0.9× 311 0.9× 281 1.1× 28 0.2× 124 1.2× 28 1.0k
Kuniharu Miyajima Japan 17 969 1.9× 263 0.8× 335 1.3× 81 0.7× 166 1.6× 37 1.5k
Roger Mouawad France 21 523 1.0× 177 0.5× 308 1.2× 42 0.4× 121 1.2× 57 968
Véronique Secq France 15 448 0.9× 251 0.7× 431 1.7× 76 0.7× 110 1.1× 41 1.1k
Wendy Prime United Kingdom 17 662 1.3× 279 0.8× 358 1.4× 25 0.2× 102 1.0× 24 1.1k
Yang‐Min Xie China 13 412 0.8× 172 0.5× 146 0.6× 51 0.5× 79 0.8× 21 645

Countries citing papers authored by Yunxiao Meng

Since Specialization
Citations

This map shows the geographic impact of Yunxiao Meng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yunxiao Meng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yunxiao Meng more than expected).

Fields of papers citing papers by Yunxiao Meng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yunxiao Meng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yunxiao Meng. The network helps show where Yunxiao Meng may publish in the future.

Co-authorship network of co-authors of Yunxiao Meng

This figure shows the co-authorship network connecting the top 25 collaborators of Yunxiao Meng. A scholar is included among the top collaborators of Yunxiao Meng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yunxiao Meng. Yunxiao Meng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhou, Shuyan, Chunyan Hou, Changmin Peng, et al.. (2025). Stabilization of RUNX1 Induced by O-GlcNAcylation Promotes PDGF-BB–Mediated Resistance to CDK4/6 Inhibitors in Breast Cancer. Cancer Research. 85(9). 1708–1724. 2 indexed citations
2.
Zhou, Shuyan, Yi Zhang, Zhuqing Li, et al.. (2025). And-1 coordinates with polymerase δ to regulate nucleotide excision repair and UVB-induced skin tumorigenesis. Nature Communications. 16(1). 9313–9313.
3.
Li, Zhuqing, Wei Zhou, Yi Zhang, et al.. (2019). ERK Regulates HIF1α-Mediated Platinum Resistance by Directly Targeting PHD2 in Ovarian Cancer. Clinical Cancer Research. 25(19). 5947–5960. 38 indexed citations
4.
Zhang, Yi, Zhuqing Li, Qiang Hao, et al.. (2019). The Cdk2–c-Myc–miR-571 Axis Regulates DNA Replication and Genomic Stability by Targeting Geminin. Cancer Research. 79(19). 4896–4910. 17 indexed citations
5.
Bi, Yalan, Yunxiao Meng, Yuchen Niu, et al.. (2019). Genome‑wide DNA methylation profile of thymomas and potential epigenetic regulation of thymoma subtypes. Oncology Reports. 41(5). 2762–2774. 13 indexed citations
6.
Zhang, Ya, Xuefeng Wu, Kai Yan, et al.. (2019). Secretome profiling identifies neuron-derived neurotrophic factor as a tumor-suppressive factor in lung cancer. JCI Insight. 4(24). 20 indexed citations
7.
Chen, Chi‐Wei, Yongming Li, Shuya Hu, et al.. (2018). DHS (trans−4,4′-dihydroxystilbene) suppresses DNA replication and tumor growth by inhibiting RRM2 (ribonucleotide reductase regulatory subunit M2). Oncogene. 38(13). 2364–2379. 45 indexed citations
8.
Bi, Yalan, Xinyu Ren, Xiaohui Bai, et al.. (2018). PD-1/PD-L1 expressions in medullary thyroid carcinoma: Clinicopathologic and prognostic analysis of Chinese population. European Journal of Surgical Oncology. 45(3). 353–358. 38 indexed citations
9.
Xie, Yanchen, Haifeng Li, Liang Sun, et al.. (2017). The Role of Osteopontin and Its Gene on Glucocorticoid Response in Myasthenia Gravis. Frontiers in Neurology. 8. 13 indexed citations
11.
Wang, Cuiping, Yang Sun, Huanwen Wu, et al.. (2015). Elevated miR-483-3p expression is an early event and indicates poor prognosis in pancreatic ductal adenocarcinoma. Tumor Biology. 36(12). 9447–9456. 19 indexed citations
12.
Zhu, Yingying, et al.. (2015). Laryngeal Neuroendocrine Carcinomas: A Retrospective Study of 14 Cases. BioMed Research International. 2015. 1–4. 7 indexed citations
13.
Huo, Zhen, Yunxiao Meng, Huanwen Wu, et al.. (2014). Adenoid cystic carcinoma of the tracheobronchial tree: clinicopathologic and immunohistochemical studies of 21 cases.. PubMed. 7(11). 7527–35. 34 indexed citations
14.
Sun, Liang, Yunxiao Meng, Yanchen Xie, et al.. (2014). CTLA4 Variants and Haplotype Contribute Genetic Susceptibility to Myasthenia Gravis in Northern Chinese Population. PLoS ONE. 9(7). e101986–e101986. 23 indexed citations
15.
Bi, Yalan, Zhen Huo, Yunxiao Meng, et al.. (2014). Extranodal Rosai-Dorfman disease involving the right atrium in a 60-year-old male. Diagnostic Pathology. 9(1). 115–115. 16 indexed citations
16.
Huo, Zhen, Di Yang, Jie Shen, et al.. (2014). Primary gliosarcoma with long-survival: report of two cases and review of literature.. PubMed. 7(9). 6323–32. 12 indexed citations
17.
Jin, Xiaona, Yunxiao Meng, Zhaohui Zhu, Hongli Jing, & Fang Li. (2013). Elevated 99mTc 3PRGD2 Activity in Benign Metastasizing Leiomyoma. Clinical Nuclear Medicine. 38(2). 117–119. 12 indexed citations
18.
Yu, Shuangni, Zhaohui Lu, Changzheng Liu, et al.. (2010). miRNA-96 Suppresses KRAS and Functions as a Tumor Suppressor Gene in Pancreatic Cancer. Cancer Research. 70(14). 6015–6025. 278 indexed citations
19.
Meng, Yunxiao, et al.. (2010). Ezrin promotes invasion and metastasis of pancreatic cancer cells. Journal of Translational Medicine. 8(1). 61–61. 69 indexed citations
20.
Li, Yujun, et al.. (2003). Relationship between expressions of E-cadherin and alpha-catenin and biological behaviors of human pancreatic cancer.. PubMed. 2(3). 471–7. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026